| Application no. and date | 07852738.9 (espacenet) (Federated) (European Patent Register), 20071011 | | Patent/reg. no. and date | DK/EP 2073805, 20150304 | | Publication date | 20090701 | | Priority no. and date | US 851450 P, 20061012 | | EP pub. no. and date |
EP 2073805 20090701 | | Effective date | | | Applicant/owner | PTC Therapeutics, Inc., 100 Corporate Court, Middlesex Business Center
South Plainfield, NJ 07080, US | | Applicant ref. no. | P81502116DK00E | | Inventor | HIRAWAT, Samit, 12 Pine Street
Chatham, NJ 07928, US,
MILLER, Langdon, 3507 Perkins Lane
Seattle, WA 98199, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/4245 (2006.01) , A61P 3/10 (2006.01) , A61P 7/00 (2006.01) , A61P 9/00 (2006.01) | | Title | Fremgangsmåder til dosering af en oralt aktiv 1,2,4-oxadiazol til terapi for suppression af nonsens-mutation | | Int. application no. | US2007021921 | | Int. publication no. | WO2008045566 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
